PPT-Maintaining patients on anticoagulants: how to do it

د حسين محمد جمعة اختصاصي الامراض الباطنة البورد العربي كلية طب الموصل 2010 Anticoagulant drugs Anticoagulant drugs can be divided into two categories oral and . Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. BALANCE. In Times of Controversy. Phil. 4:5. . Let your moderation be known unto all men. The Lord is at hand.. [By Ron Halbrook]. 2. Maintaining BALANCE. Introduction:. 1. . Phil. 4:5 . . Mature, Well-balanced Attitude. Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. Overview of Anticoagulation in . Interventional Cardiology. Rivaroxaban in Patients With Recent ACS:. ATLAS ACS 2-TIMI 51. Apixaban After ACS: APPRAISE-2. How Do You Treat Complex Patients?. ACC/AHA Guidelines. What are Direct-Acting Oral Anticoagulants DOACsANSWERS by heartTreatments TestscontinuedAdhere to your medication regimen and do not abruptly stop taking your DOACs without 31rst talking with your d University of Louisville Physicians . Cardiovascular diseases overview . Goals of Discussion. Disease pathologies. Prevalence and Risk factors. Strategies for treatment . Newer techniques. Team approach . Dr Than . Kyaw. 27 February 2012. COAGULATION. Complex process of blood clotting. Important part of . hemostasis. Cessation of blood loss from damaged vessel(s). Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis). . This presentation is based on the . December 2013. AHRQ WebM&M Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Margaret . C. Fang. , MD, MPH, University of California, San Francisco. , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. ?. That . major bleeding . occurs in about . 6.5% of patients on anticoagulants.. . That’s. . 1 patient in 15. . and commonly, GI Bleeding.. That . 1% . is . fatal bleeding . such as intracranial hemorrhage.. existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Christopher B. Granger, MD. On behalf of the IMPACT-AF . Steering. Committee and Investigators. Background. AF is common (34 million people worldwide). AF is associated with a 5-fold increased risk of stroke. ischaemic. attack in patients with. a diagnosis of resolved atrial fibrillation: . retrospective cohort. . studies.. Nicola J Adderley, . Krishnarajah. . Nirantharakumar. , Tom Marshall.. BMJ 2018.